INSR and Alzheimer disease: Recent studies indicate that active insulin receptors are expressed in astrocytes; the absence of insulin receptors in astrocytes reduces their adenosine triphosphate (ATP) release capability, exacerbating AD‐like symptoms in 5XFAD mice (Cai et al. 2018; Chen et al. 2023).